Antioxidant response induced by serum withdrawal protects HL-60 cells against inhibition of NAD(P)H:quinone oxidoreductase 1

BioFactors

Volumn 18, Issue 1-4, 2003, Pages 219-228

  Gómez Díaz, Consuelo ^a   Bello, Rosario I ^a   López Lluch, Guillermo ^b   Forthoffer, Nathalie ^a   Navas, Plácido ^b   Villalba, José M ^a,c  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^c Depto de Biología Celular   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; DICOUMAROL; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) INHIBITOR; UBIQUINONE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL GROWTH; CELL PROTECTION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0347419376     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520180224     Document Type: Conference Paper

References (38)

1. S. Alexandre, C. Rast, G. Nguyen-Ba and P. Vasseur, Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in Syrian hamster embryo cells, Experimental Cell Research 255 (2000), 30-39.
2. A. Anwar, D. Dehn, D. Siegel, J.K. Kepa, L.J. Tang, J.A. Pietenpol and D. Ross, Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems, Journal of Biological Chemistry 278 (2003), 10368-10373.
3. G. Asher, J. Lotem, B. Cohen, L. Sachs and Y. Shaul, Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1, Proceedings of the National Academy of Sciences USA 98 (2001), 1188-1193.
4. G. Asher, J. Lotem, R. Kama, L. Sachs and Y. Shaul, NQO1 stabilizes p53 through a distinct pathway, Proceedings of the National Academy of Sciences USA 99 (2002), 3099-3114.
5. G. Asher, J. Lotem, L. Sachs, C. Kahana and Y Shaul, Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1, Proceedings of the National Academy of Sciences USA 99 (2002), 13125-13130.
6. M.P. Barroso, C. Gómez-Díaz, G. López-Lluch, M.M. Malaón, F.L. Crane and P. Navas, Ascorbate and alpha-tocopherol prevent apoptosis induced by serum removal independent of Bcl-2, Archives of Biochemistry and Biophysics 343 (1997), 243-248.
7. M.P. Barroso, C. Gómez-Díaz, J.M. Villalba, M.I. Burón, G. López-Lluch and P. Navas, Plasma membrane ubiquinone controls ceramide production and prevents cell death induced by serum withdrawal, Journal of Bioenergetics and Biomembranes 29 (1997), 259-267.
8. R.I. Bello, C. Gómez-Díaz, F. Navarro, F.J. Alcaín and J.M. Villalba, Expression of NAD(P)H:quinone oxidoreductase 1 in HeLa cells: role of hydrogen peroxide and growth phase, Journal of Biological Chemistry 276 (2001), 44379-44384.
9. R.I. Bello, V.E. Kagan, V. Tyurin, F. Navarro, F.J. Alcaín and J.M. Villalba, Regeneration of lipophilic antioxidants by NAD(P)H:quinone oxidoreductase 1, Protoplasma (2003), (in press).
10. R.E. Beyer, J. Segura-Aguilar, D. di Bernardo, M. Cavazzoni, R. Fato, D. Fiorentini, M.C. Galli, M. Setti, L. Landi and G. Lenaz, The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems, Proceedings of the National Academy of Sciences USA 93 (1996), 2528-2532.
11. J.M. Brown, C.J. Beehler, E.M. Berger, M.A. Grosso, G.J. Whitman, L.S. Terada, J.A. Leff, A.H. Harken and J.E. Repine, Albumin decreases hydrogen peroxide and reperfusion injury in isolated rat hearts, Inflamation 13 (1989), 583-589.
12. E. Cadenas, Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism, Biochemical Pharmacology 49 (1995), 127-140.
13. S.D. Catz and J.L. Johnson, Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer, Oncogene 20 (2001), 7342-7351.
14. J.V Cross, J.C. Deak, E.A. Rich, Y. Qian, M. Lewis, L.A. Parrot, K. Mochida, D. Gustafson, S. Vande Pol and D.J. Templeton, Quinone reductase inhibitors block SAPK/JNK and NFκB pathways and potentiate apoptosis, Journal of Biological Chemistry 274 (1999), 31150-31154.
15. L. Ernster, DT-diaphorase, Methods in Enzymology 10 (1967), 309-317.
16. L. Ernster and G. Dallner, Biochemical, physiological and medical aspects of ubiquinone function, Biochimica et Biophysica Acta 1271 (1995), 195-204.
17. J. Feuillard, M. Schuhmacher, S. Kohanna, M. Asso-Bonnet, F. Ledeur, R. Joubert-Caron, P. Bissieres, A. Polack, G.W. Bornkamm and M. Raphael, Inducible loss of NF-κB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes, Blood 95 (2000), 2068-2075.
18. N. Forthoffer, S.F. Martín, C. Gómez-Díaz, R.I. Bello, M.I. Burón, J.C. Rodríguez-Aguilera, P. Navas and J.M. Villalba, A novel plasma membrane quinone reductase and NAD(P)H:quinone oxidoreductase 1 are upregulated by serum withdrawal in human promyelocytic HL-60 cells, Journal of Bioenergetics and Biomembranes 34 (2002), 209-219.
19. A. Gaikwad, D.J. Long, J.L. Stringer and A.K. Jaiswal, In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue, Journal of Biological Chemistry 276 (2001), 22559-22564.
20. C.A. Heckman, J.W. Mehew and L.M. Boxer, NF-κB activates Bcl-2 expression in t(14;18) lymphoma cells, Oncogene 21 (2002), 3898-3908.
21. A.K. Jaiswal, Regulation of genes encoding NAD(P)H:quinone oxidoreductases, Free Radicals in Biology and Medicine 29 (2000), 254-262.
22. D.K. Kim, E.S. Cho, B.R. Lee and H.-D. Um, NF-κB mediates the adaptation of human U937 cells to hydrogen peroxide, Free Radicals in Biology and Medicine 30 (2001), 563-571.
23. Y.H. Kim, M. Takahashi, N. Noguchi, E. Suzuki, K. Suzuki, N. Taniguchi and E. Niki, Inhibition of c-Jun expression induces antioxidant enzymes under serum deprivation, Archives of Biochemistry and Biophysics 374 (2000), 339-346.
24. B.R. Lee and H.-D. Um, Hydrogen peroxide suppresses U937 cell death by two different mechanisms depending on its concentration, Experimental Cell Research 248 (1999), 430-438.
25. R. Li, M.A. Bianchet, P. Talalay and L.M. Amzel, The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction, Proceedings of the National Academy of Sciences USA 92 (1995), 8846-8850.
26. C. Lind, E. Cadenas, P. Hochstein and L. Ernster, DT-diaphorase: purification, properties, and function, Methods in Enzymology 186 (1990), 287-301.
27. D.J. Long 2nd, R.L. Waikel, X.J. Wang, L. Perlaky, D.R. Roop and A.K. Jaiswal, NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis, Cancer Research 60 (2000), 5913-5915.
28. I. Petitpas, A.A. Bhattacharya, S. Twine, M. East and S. Curry, Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I, Journal of Biological Chemistry 276 (2001), 22804-22809.
29. R.M. Phillips, A.M. Burger, P.M. Loadman, C.M. Jarrett, D.J. Swaine and H.H. Fiebig, Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development, Cancer Research 60 (2000), 6384-6390.
30. D. Siegel, E.M. Bolton, J.A. Burr, D.C. Liebler and D. Ross, The reduction of alpha-tocopherolquinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherolhydroquinone as a cellular antioxidant, Molecular Pharmacology 52 (1997), 300-305.
31. L.M. Siemankowski, J. Morreale, B.D. Butts and M.M. Briehl, Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase, Cancer Research 60 (2000), 3638-3644.
32. A.F.G. Slater, C. Stefan, I. Nobel, D.J. van den Dobbelsteen and S. Orrenius, Intracellular redox changes during apoptosis, Cell Death and Differentiation 3 (1996), 57-62.
33. C.M. Stoscheck, Quantitation of protein, Methods in Enzymology 182 (1990), 50-68.
34. M. Tamatani, Y.H. Che, H. Matsuzaki, S. Ogawa, H. Okado, S. Miyake, T. Mizuno and M. Tohyama, Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFκB activation in primary hippocampal neurons, Journal of Biological Chemistry 274 (1999), 8531-8538.
35. J.G. Vethanayagam, E.H. Green, R.C. Rose and A.M. Bode, Glutathione-dependent ascorbate recycling activity of rat serum albumin, Free Radicals in Biology and Medicine 26 (1999), 1591-1598.
36. A.G. Wiese, R.E. Pacifici and K.J.A. Davies, Transient adaptation to oxidative stress in mammalian cells, Archives of Biochemistry and Biophysics 318 (1995), 231-240.
37. D. Wolf and A. Rotter, Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells, Proceedings of the National Academy of Sciences USA 82 (1985), 790-794.
38. W.D. Wosilait, M.P. Ryan and K.H. Byington, Uptake of anticoagulants by isolated rat hepatocytes, Drug Metabolism and Disposition 9 (1981), 80-84.